If The Vaccine Is So Safe, Why Are High Level FDA Vaccine Regulators Resigning?

Share The Story

This is one of those stories which makes me raise a brow…….

Resignations are nothing out of the ordinary, but resignations of two senior level vaccine regulators at The FDA, right after Pfizer’s vaccine gained FDA approval?

Perhaps they left because they have ethical problems with the push for mass vaccination and refuse to be a part of what is clearly an obvious push by drug companies to generate profit.

Indeed, reports are indicating that they had problems with the current administration’s booster policies and pushes for the public to get booster vaccines without adequate research.

Sources indicate that both have been at The FDA for substantial periods of time, and it really begs the question, why leave now?

There are only a couple of reasons I can think of……

Take a look through these reports, and let us know what you think:

The Epoch Times had more details:

According to a memo that was sent by Peter Marks, the head of FDA’s Center for Biologics Evaluation and Research (CBER) that oversees OVRR, and obtained by The Epoch Times, Gruber is leaving on Oct. 31. Krause is leaving sometime in November, the memo said.

Marks said in the memo that he would serve as the OVRR’s acting director while the FDA carries out a search for who should lead the division.

The memo did not provide a reason for why Gruber and Krause are leaving.

A LinkedIn profile for Gruber shows she worked for the FDA for 32 years and served as the OVRR’s director for about a decade. Krause, meanwhile, has worked for the FDA for about 11 years, according to his profile.

CNBC noted the two regulator’s frustration with The Biden Administration’s overreach on booster shots:

Endpoints News, a biotech industry publication, reported that the officials are leaving because they’re frustrated that the Centers for Disease Control and Prevention and its advisory committee are involved in decisions they think should be up to the FDA.

The final straw was when the White House got ahead of the agency on booster shots, according to Endpoints News, citing a former senior FDA leader.

When asked at a briefing later Tuesday whether the departures will affect trust in the FDA, White House Covid czar Jeff Zients said the decision to distribute boosters was made by a number of senior health officials, including acting FDA Commissioner Dr. Janet Woodcock. 


Share The Story

Add Comment